ArticleInternational journal of oncology2011

p53, HER2 and tumor cell apoptosis correlate with clinical outcome after neoadjuvant bevacizumab plus chemotherapy in breast cancer.

Sherry X Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.